Cell with reduced ppgppase activity
AssigneeEvonik Industriaes AG
InventorsFrank Schneider, Caroline Gerth
Life of this patent
Estimating the term…
Loading patent…
AssigneeEvonik Industriaes AG
InventorsFrank Schneider, Caroline Gerth
Estimating the term…
The present invention relates to a cell which is genetically modified over its wild type in such a way that it has a reduced ppGppase activity relative to its wild type, and preferably an essential amino acid, even more preferably an essential amino acid derived from serine, most preferably methionine or tryptophan, to a feed additive comprising such a cell, to a method of preparing a cell overproducing essential amino acid, more preferably an essential amino acid derived from serine, most preferably methionine or tryptophan, comprising preparing a cell having a knocked-out gene coding for a ppGppase, and to a method of preparing an essential amino acid, more preferably an essential amino acid derived from serine, most preferably methionine or tryptophan, comprising the steps of a) culturing the cell according to the first aspect of the present invention or to any of its embodiments, and b) optionally: purifying the amino acid.
Cell which is genetically modified over its wild type in such a way that it has a reduced ppGppase activity relative to its wild type and overproduces an essential amino acid.
Method of preparing a cell overproducing an essential amino acid, more preferably an essential amino acid derived from serine, comprising preparing a cell having a knocked-out gene coding for a ppGppase, preferably without having a reduced (p)ppGpp-synthetase activity relative to its wild type, wherein said ppGppase is selected from the group comprising the amino acid sequences SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6 and also variants thereof, and culturing said cell, with optional purification of the amino acid.
Dependencies are inferred from the claim text.